11
Apr 2023
Life-extending cervical cancer drug to be offered by NHS in England
New recommendations say life-extending drug for advanced cervical cancer Pembrolizumab, is to be made available to NHS patients in England. The cost of the immunotherapy will be met by the Cancer Drugs Fund, which aims to make promising treatments available earlier while data is still being gathered on cost-effectiveness. According to Cancer Research…